中国以人群免疫巩固新冠疫情成功遏制的疫苗接种策略和挑战。
Vaccination strategy and challenges for consolidating successful containment of covid-19 with population immunity in China.
机构信息
National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
出版信息
BMJ. 2021 Dec 1;375:e066125. doi: 10.1136/bmj-2021-066125.
Abstract
argue that sustained elimination of SARS-CoV-2 in China offers flexibility in covid-19 vaccination policy and discuss the anticipated challenges and systematic monitoring necessary to keep the immunisation component of the response on track
摘要
认为中国持续消除 SARS-CoV-2 为新冠病毒疫苗接种政策提供了灵活性，并讨论了为保持应对措施中的免疫部分按计划进行而预期面临的挑战和系统监测。
Zotero 插件